The possibility of a causal influence of emotional stress, especially of stressful life events, on the course of various skin diseases has long been postulated. Clinical wisdom and experience, as well as many anecdotal observations and uncontrolled case series, support this opinion. We reviewed the available evidence on the role of stressful life events in triggering or exacerbating skin diseases. The role of stressful events in vitiligo, lichen planus, acne, pemphigus and seborrhoeic dermatitis was either controversial or insufficiently explored. The role of stressful events in psoriasis, alopecia areata, atopic dermatitis and urticaria was apparently clearer. However, only a few studies met acceptable methodological standards for stress measurement. Also, few studies considered common potential confounding factors (e.g. age, duration of illness, familial factors), and no study controlled adequately for the influence of other crucial factors (e.g. discontinuation of treatment, seasonal effects). Adding that the large majority of studies were retrospective, it seems wise to conclude that only preliminary evidence has been published so far on the role of stressful life events in bringing on or worsening any dermatological disease. Further research is mandatory, either in the form of prospective studies or, more feasibly, of well-designed case-control studies with adequate statistical power. Future studies should also pay more attention to protective as well as vulnerability factors in stressful events. Further, it would be important to investigate other sources of psychological stress, such as chronic stress and everyday stress. Measuring stress appraisal, although difficult, would also be important.

Keywords:
Psychological stress, Life change events, Skin diseases, Psoriasis, Alopecia areata, Atopic dermatitis, Urticaria, Acne, Vitiligo, Lichen planus
1.
Koblentzer CS: Psychosomatic concepts in dermatology. Arch Dermatol 1983;119:501–512.
2.
Gupta MA, Voorhees JJ: Psychosomatic dermatology: Is it relevant? Arch Dermatol 1990;126:90–93.
3.
Hughes JE, Barraclough BM, Hamblin LG, White JE: Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51–54.
4.
Gupta MA, Gupta AK: Psychodermatology: An update. J Am Acad Dermatol 1996;34:1030–1046.
5.
Van Moffaert M: Psychodermatology: An overview. Psychother Psychosom 1992;58:125–136.
6.
Rajka G: Atopic dermatitis: Correlation of environmental factors with frequency. Int J Dermatol 1986;25:301–304.
7.
Dahan S, Launais B, Lasserre J, et al: Stress et peau: avis du médecin, avis du patient. Nouv Dermatol 1998;17:90–93.
8.
Zorrilla EP, McKay JR, Luborsky L, Schmidt K: Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry 1996;153:626–635.
9.
Green J, Kocsis A: Psychological factors in recurrent genital herpes. Genitourin Med 1997;73:253–258.
10.
Cohen S, Kessler RC, Underwood Gordon L: Strategies for measuring stress in studies of psychiatric and physical disorders; in Cohen S, Kessler RC, Underwood Gordon L (eds): Measuring Stress. New York, Oxford University Press, 1995.
11.
Hawkins NG, Davies R, Holmes TH: Evidence of psychosocial factors in the development of pulmonary tuberculosis. Am Rev Tuberc Pulm Dis 1957;75:768–780.
12.
Holmes TH, Rahe RH: The social readjustment rating scale. J Psychosom Res 1967;11:213–218.
13.
Sarason IG, Johnson JH, Siegel JM: Assessing the impact of life changes: Development of the life experiences survey. J Consult Clin Psychol 1978;46:932–946.
14.
Turner RJ, Wheaton B: Checklist measurement of stressful life events; in Cohen S, Kessler RC, Underwood Gordon L (eds): Measuring Stress. New York, Oxford University Press, 1995.
15.
Wethington E, Brown GW, Kessler RC: Interview measurement of stressful life events; in Cohen S, Kessler RC, Underwood Gordon L (eds): Measuring Stress. New York, Oxford University Press, 1995.
16.
Paykel ES: Methodological aspects of life events research. J Psychosom Res 1983;27:341–352.
17.
Raphael EG, Cloitre M, Dohrenwend BP: Problems of recall and misclassification with checklist methods of measuring stressful life events. Health Psychol 1991;10:62–74.
18.
Cleary P: A checklist for life events research. J Psychosom Res 1980;24:199–207.
19.
Katugampola G, Katugampola S: Psoriasis and stress. Int J Dermatol 1990;29:234.
20.
Ros AM, Eklund G: Photosensitive psoriasis: An epidemiologic study. J Am Acad Dermatol 1987;17:752–758.
21.
Nevitt GJ, Hutchinson PE: Psoriasis in the community: Prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 1996;135:533–537.
22.
Fortune DG, Richards HL, Main CJ, Griffiths CE: What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39:196–201.
23.
Susskind W, McGuire RJ: The emotional factor in psoriasis. Scott Med J 1959;4:503–507.
24.
De la Brassinne M, Neys C: Le psoriasis en tant que phénomène psychosomatique. Acta Psychiatr Belg 1986;86:36–41.
25.
Hellgren L: Psoriasis: A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol 1964;44:191–207.
26.
Bolgert M, Soulé M: Origine psychogène de la psoriasis. Ann Dermatol Syphiligr 1955;82:252–256.
27.
Polenghi MM, Gala C, Citeri A, Manca G, Guzzi R, Barcella M, Finzi A: Psychoneurophysiological implications in the pathogenesis and treatment of psoriasis. Acta Derm Venereol Suppl 1989;146:84–86.
28.
Polenghi MM, Molinari E, Gala C, Guzzi R, Garutti C, Finzi AF: Experience with psoriasis in a psychosomatic dermatology clinic. Acta Derm Venereol Suppl 1994;186:65–66.
29.
Boyd AS, Menter A: Erythrodermic psoriasis: Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989;21:985–991.
30.
Mazzetti M, Mozzetta A, Soavi GC, Andreoli E, Foglio Bonda PG, Puddu P, Decaminada F: Psoriasis, stress and psychiatry: Psychodynamic characteristics of stressors. Acta Derm Venereol Suppl 1994;186:62–64.
31.
Nyfors A, Lemholt K: Psoriasis in children: A short review and a survey of 245 cases. Br J Dermatol 1975;92:437–442.
32.
Beare JM, Burrows D, Merrett JD: The effects of mental and physical stress on the incidence of skin disorders. Br J Dermatol 1978;98:553–558.
33.
Farber EM, Bright RD, Nall ML: Psoriasis: A questionnaire survey of 2,144 patients. Arch Dermatol 1968;98:248–259.
34.
Braun-Falco O, Burg G, Farber EM: Psoriasis: Eine Fragebogenstudie bei 536 Patienten. Münch Med Wochenschr 1972;114:1105–1110.
35.
Farber EM, Nall ML: The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1–18.
36.
Ginsburg IH: Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995;13:793–804.
37.
Baughmann RD, Sobel R: Psoriasis, stress, and strain. Arch Dermatol 1971;103:599–605.
38.
Park BS, Youn JI: Factors influencing psoriasis: An analysis based upon the extent of involvement and clinical type. J Dermatol 1998;25:97–102.
39.
Seville RH: Psoriasis and stress. Br J Dermatol 1977;97:297–302.
40.
Shuster S: Stress and psoriasis. Br J Dermatol 1979;100:614–616.
41.
Fava GA, Perini GI, Santonastaso P, Veller Fornasa C: Life events and psychological distress in dermatologic disorders: Psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980;53:277–282.
42.
Lyketsos GC, Stratigos GC, Tawil G, Psaras M, Lyketsos CG: Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia. Psychother Psychosom 1985;44:122–131.
43.
Payne RA, Rowland Payne CM, Marks R: Stress does not worsen psoriasis? A controlled study of 32 patients. Clin Exp Dermatol 1985;10:239–245.
44.
Polenghi MM, Gala C, Citeri A, Russo R, Pigatto PD, Altomare GF: Psoriasi ed eventi stressanti. G Ital Dermatol Venereol 1987;122:167–170.
45.
Baldaro B, Brocani G, Bossi G, Offidani AM, Novelli N, Ferri AM: Psoriasi: incidenza di eventi stressanti nei sei mesi precedenti la comparsa della malattia. Med Psicosom 1989;34:47–51.
46.
Al’Abadie MS, Kent GG, Gawkrodger DJ: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199–203.
47.
Poikolainen K, Reunala T, Karvonen J: Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994;130:473–477.
48.
Fortune DG, Main CJ, O’Sullivan TM, Griffiths CEM: Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:755–760.
49.
Harvima RJ, Viinamäki H, Harvima IT, Naukkarinen A, Savolainen L, Aalto ML, Horsmanheimo M: Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol 1996;76:467–471.
50.
Gaston L, Lassonde M, Bernier-Buzzanga J, Hodgins S, Crombez JC: Psoriasis and stress: A prospective study. J Am Acad Dermatol 1987;17:82–86.
51.
Gaston L, Crombez JC, Lassonde M, Bernier-Buzzanga J, Hodgins S: Psychological stress and psoriasis: Experimental and prospective correlational studies. Acta Derm Venereol Suppl 1991;156:37–43.
52.
Terashima Y, Ichikawa T, Suzuki T, Koizumi J: An adult case of psychogenic alopecia universalis. Jpn J Psychiatry Neurol 1989;43:585–589.
53.
Takahashi S, Tani T, Suzuki R, Okura S, Higashitani A, Hirose Y, Sumioka H, Morikawa M: A case of Crohn’s disease preceded by alopecia universalis due to psychological stress. Jpn J Psychosom Med 1996;36:337–342.
54.
Zalka AD, Byarlay JA, Goldsmith LA: Alopecia à deux: Simultaneous occurrence of alopecia in a husband and wife. Arch Dermatol 1994;130:390–392.
55.
MacAlpine I: Is alopecia areata psychosomatic? A psychiatric study. Br J Dermatol 1958;70:117–131.
56.
Van der Steen P, Boezeman J, Duller P, Happle R: Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol 1992;72:279–280.
57.
Muller S, Winkelmann RK: Alopecia areata: An evaluation of 736 patients. Arch Dermatol 1963;88:290–297.
58.
Gupta MA, Gupta AK, Watteel GN: Stress and alopecia areata: A psychodermatologic study. Acta Derm Venereol 1997;77:296–298.
59.
Gip L, Lodin A, Molin L: Alopecia areata: A follow-up investigation of outpatient material. Acta Derm Venereol 1969;49:180–188.
60.
De Waard-van der Spek FB, Oranje AP, De Raeymaecker DM, Peereboom-Wynia JD: Juvenile versus maturity-onset alopecia areata – A comparative retrospective clinical study. Clin Exp Dermatol 1989;14:429–433.
61.
De Weert J, Temmermann L, Kint A: Alopecia areata: A clinical study. Dermatologica 1984;168:224–229.
62.
Anderson J: Alopecia areata: A clinical study. Br Med J 1950;2:1250–1252.
63.
Reinhold M: Relationship of stress to the development of symptoms in alopecia areata and chronic urticaria. Br Med J 1960;1:846–849.
64.
Wygldowska-Kania M, Bogdanowski T: Czynniki psychiczne w wywiadzie pacjentów z lysieniem plackowatym-doniesienie wstpne. Psychiatr Pol 1996;30:669–676.
65.
Dugas M, Le Heuzey MF: Stress, détresse et pelade: étude de 60 observations personelles. Acta Paedopsychiatr 1983;49:221–237.
66.
De Graciansky P, Stern E: Le rôle des facteurs psychiques dans l’étiologie de quelques dermatoses. Ann Dermatol Syphiligr 1952;79:5–19.
67.
Mehlman RD, Griesemer RD: Alopecia areata in the very young. Am J Psychiatry 1968;125:605–614.
68.
Veller Fornasa C, Cipriani R, Peserico A, Rabito C: Eventi stressanti e alopecia areata. G Ital Dermatol Venereol 1982;117:211–212.
69.
Perini GI, Veller Fornasa C, Cipriani R, Bettin A, Zecchino F, Peserico A: Life events and alopecia areata. Psychother Psychosom 1984;41:48–52.
70.
Baldaro B, Brocani G, Bossi G, Offidani AM, Novelli N, Ferri AM: Incidenza di eventi stressanti nei sei mesi precedenti la comparsa di alopecia areata. Med Psicosom 1989;34:271–275.
71.
Russiello F, Arciero G, Decaminada F, Corona R, Ferrigno L, Fucci M, Pasquini M, Pasquini P: Stress, attachment and skin disease: A case-control study. J Eur Acad Dermatol Venereol 1995;5:234–239.
72.
Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J, Stratigos J: Children with alopecia areata: Psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997;36:678–684.
73.
Invernizzi G, Gala C, Russo R, Polenghi M, Manca G, Conte G: Life events and personality factors in patients with alopecia areata. Med Sci Res 1987;15:1219–1220.
74.
Paga G, Faina P, Teodori A, Angelini E, Biondi M, Ruvinetti S, Pancheri P: Psychological factors in alopecia areata: Results from a preliminary, controlled study. New Trends Exp Clin Psychiatry 1992;8:73–79.
75.
Ferrando Roqueta FJ, Corral Blanco C, Lobo Satue A, Grasa Jordan MP: Estudio de los fenomenos de estrés y su relacion con variables psicopatologicas, clinicas e immunologicas en pacientes con alopecia areata. Actas Dermosifiliogr 1996;87:597–609.
76.
Al-Khawajah M: Alopecia areata and associated diseases in Saudi patients. Ann Saudi Med 1991;11:651–654.
77.
York J, Nicholson T, Minors P, Duncan DF: Stressful life events and loss of hair among adult women: A case-control study. Psychol Rep 1998;82:1044–1046.
78.
Greenhill MH, Finesinger JE: Neurotic symptoms and emotional factors in atopic dermatitis. Arch Dermatol Syphilol 1942;46:187–200.
79.
Wittkower E, Edgell PG: Eczema: A psychosomatic study. Arch Dermatol Syphilol 1951;63:207–219.
80.
Ullman KC, Moore RW, Reidy M: Atopic eczema: A clinical psychiatric study. J Asthma Res 1977;14:91–99.
81.
Rechardt M, Saarinen J: Psychic factors and immunological reactions in atopic dermatitis. Acta Derm Venereol Suppl 1991;156:56.
82.
Schudel P, Wütrich B: Klinische Verlaufsbeobachtungen bei Neurodermitis atopica nach dem Kleinkindesalter: Eine katamnestische Untersuchung anhand von 121 Fällen. Z Hautkr 1985;60:479–486.
83.
Lammintausta K, Kalimo K, Ritala R, Forsten Y: Prognosis of atopic dermatitis: A prospective study in early adulthood. Int J Dermatol 1991;30:563–568.
84.
Kissling S, Wütrich B: Verlauf der atopischen Dermatitis nach dem Kleinkindalter. Hautarzt 1993;44:569–573.
85.
Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S, Ichihashi M: Effect of stress on atopic dermatitis: Investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol 1999;104:173–176.
86.
Gil KM, Keefe FJ, Sampson HA, McCaskill CC, Rodin J, Crisson JE: The relation of stress and family environment to atopic dermatitis symptoms in children. J Psychosom Res 1987;31:673–684.
87.
King RM, Wilson GV: Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991;35:697–706.
88.
Gupta MA, Gupta AK, Schork NJ, Ellis CN: Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36–40.
89.
Buhk H, Muthny FA: Psychophysiologische und psychoneuroimmunologische Ergebnisse zur Neurodermitis: Übersicht und kritische Bilanz. Hautarzt 1997;48:5–11.
90.
Bergbrant IM: Seborrhoeic dermatitis and Pityrosporum ovale: Cultural, immunological and clinical studies. Acta Derm Venereol Suppl 1991;167:1–36.
91.
Papadopoulos L, Bor R, Legg C, Hawk JL: Impact of life events on the onset of vitiligo in adults: Preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 1998;23:243–248.
92.
Panconesi E, Hautmann G: Psychophysiology of stress in dermatology: The psychobiologic pattern of psychosomatics. Dermatol Clin 1996;14:399–421.
93.
Michaelsson G: Chronic urticaria. Acta Derm Venereol 1969;49:404–416.
94.
Teshima H, Kubo C, Kihara H, Imada Y, Nagata S, Ago Y, Ikemi Y: Psychosomatic aspects of skin disease form the standpoint of immunology. Psychother Psychosom 1982;37:165–175.
95.
Stewart JH, Goodman MM: Earthquake urticaria. Cutis 1989;43:340.
96.
Rees L: An aetiological study of chronic urticaria and angioneurotic oedema. J Psychosom Res 1957;2:172–189.
97.
Niemeier V, Kupfer J, Demmelbauer-Ebner M, Stangier U, Effendy I, Gieler U: Coping with acne vulgaris. Dermatology 1998;196:108–115.
98.
Sulzberger NB, Zaidens SH: Psychogenic factors in dermatologic disorders. Med Clin North Am 1948;32:669–685.
99.
Shalita AR: Treatment of refractory acne. Dermatology 1980;3:23–24.
100.
Lorenz TH, Graham DT, Wolf S: The relation of life stress and emotions to human sebum secretion and to the mechanism of acne vulgaris. J Lab Clin Med 1953;41:11–28.
101.
Griesemer RD: Emotionally triggered disease in dermatological practice. Psychiatr Ann 1978;8:407–412.
102.
Harrington CI: Post-adolescent acne and marital break-up. Br J Dermatol 1997;137:478–479.
103.
Altmann J, Perry HO: Variations and course of lichen planus. Arch Dermatol 1961;84:179–192.
104.
Weltmann G, Weitz R: Über die Bedeutung psychosomatischer Einflüsse für die Enstehung des Lichen ruber planus. Hautarzt 1966;17:7–16.
105.
Cossidente A, Devoto G, Melli MC, Giorgini S: Indagine psicologico-psichiatrica su cento casi di lichen planus. G Ital Dermatol Venereol 1982;117:337–340.
106.
Tompkins JK: Lichen planus: Statistical study of 41 cases. Arch Dermatol 1955;71:515–519.
107.
Burkhart NW, Burker EJ, Burkes EJ, Wolfe L: Assessing the characteristics of patients with oral lichen planus. J Am Dent Assoc 1996;127: 648–656.
108.
Allen CM, Beck FM, Rossie KM, Kaul TJ: Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986;61:44–46.
109.
Baldaro B, Ercolani M, Ramoni R, Varotti C: Eventi stressanti e sintomi psicologici nel lichen ruber planus. Med Psicosom 1987;32:307–314.
110.
Perry HO, Brunsting LA: Pemphigus foliaceus. Arch Dermatol 1965;91:10–23.
111.
Brenner S, Bar-Nathan EA: Pemphigus vulgaris triggered by emotional stress. J Am Acad Dermatol 1984;11:524–525.
112.
Tamir A, Ophir J, Brenner S: Pemphigus vulgaris triggered by emotional stress. Dermatology 1994;189:210.
113.
Cremniter D, Baudin M, Roujeau JC, Prost C, Consoli SG, Francés C, Chosidow O: Stressful life events as potential triggers of pemphigus. Arch Dermatol 1998;134:1486–1487.
114.
Karvonen J, Poikolainen K, Reunala T, Juvakoski T: Alcohol and smoking: Risk factors for infectious eczematoid dermatitis? Acta Derm Venereol 1992;72:208–210.
115.
Capoore HS, Rowland Payne CME, Goldin D: Does psychological intervention help chronic skin conditions? Postgrad Med J 1998;74:662–664.
116.
Biondi M, Picardi A: Psychological stress and neuroendocrine function in humans: The last two decades of research. Psychother Psychosom 1999;68:114–150.
117.
Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology, ed 2. New York, Academic Press, 1990.
118.
Farber EM, Nickoloff BJ, Recht B, Fraki JE: Stress, symmetry, and psoriasis: Possible role of neuropeptides. J Am Acad Dermatol 1986;14:305–311.
119.
Lotti T, Hautmann G, Panconesi E: Neuropeptides in skin. J Am Acad Dermatol 1995;33:482–496.
120.
Luger TA, Lotti T: Neuropeptides: Role in inflammatory skin diseases. J Eur Acad Dermatol Venereol 1998;10:207–211.
121.
Biondi M, Picardi A: Clinical and biological aspects of bereavement and loss-induced depression: A reappraisal. Psychother Psychosom 1996;65:229–245.
122.
Cobb S: Social support as a moderator of life stress. Psychosom Med 1976;38:300–314.
123.
Mikulincer M, Florian V: The relationship between adult attachment styles and emotional and cognitive reactions to stressful events; in Simpson JA, Rholes WS (eds): Attachment Theory and Close Relationships. New York, Guilford Press, 1998.
124.
Mahoney MJ (ed): Cognitive and Constructive Psychotherapies. New York, Springer, 1995.
125.
Neimeyer RA, Raskin JD: Construction of Disorder: Meaning-Making Frameworks for Psychotherapy. New York, American Psychological Association, 2000.
126.
Guidano VF: The Self in Process. New York, Guilford Press, 1991.
127.
Rabkin JG, Struening EL: Life events, stress, and illness. Science 1976;194:1013–1020.
128.
Monroe SM, Kelley JM: Measurement of stress appraisal; in Cohen S, Kessler RC, Underwood Gordon L (eds): Measuring Stress. New York, Oxford University Press, 1995.
129.
Neimeyer RA: Constructivist approaches to the measurement of meaning; in Neimeyer GJ (ed): Casebook of Constructivist Assessment. Newbury Park, Sage, 1992.
130.
Fava GA, Sonino N. Psychosomatic medicine: Emerging trends and perspectives. Psychother Psychosom 2000;69:184–197.
131.
Engel GL: The need for a new medical model: A challenge for biomedicine. Science 1977;196:129–136.
132.
Engel GL: The clinical application of the biopsychosocial model. Am J Psychiatry 1980;137:535–544.
133.
Ryff CD, Singer BH: Biopsychosocial challenges of the new millennium. Psychother Psychosom 2000;69:170–177.
134.
Wessely SC, Lewis GH: The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155:686–691.
135.
Attah Johnson FY, Mostaghimi H: Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 1995;34:244–248.
136.
Aktan S, Ozmen E, Sanli B: Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998;197:230–234.
137.
Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P: Psychiatric morbidity in dermatological outpatients: An issue to be recognised. Br J Dermatol, 2000;143:983–991.
138.
Gould WM, Gragg TM: A dermatology-psychiatry liaison clinic. J Am Acad Dermatol 1983;9:73–77.
139.
Koblentzer CS: Liaison dermatology. Int J Dermatol 1986;25:28–30.
140.
Cotterill JA: Psychiatry and the skin. Br J Hosp Med 1989;42:401–404.
141.
Woodruff P, Higgins EM, duVivier AW, Wessely S: Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997;19:29–35.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.